Efficacy and Safety of Yangxin Shengmai Granules for the Treatment of Stable Angina Pectoris: Randomised, Double Blind, Placebo Controlled Trial

NCT04270071 Phase 4 UNKNOWN

This study is a randomized, double-blind, placebo-controlled, parallel clinical trial in Chinese population with stable angina pectoris. The purpose is to determine the efficacy and safety of Yangxin Shengmai Granules in the treatment of stable angina pectoris.

Details

Lead sponsor	Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Phase	Phase 4
Status	UNKNOWN
Enrolment	80
Start date	2020-12
Completion	2021-12

Conditions

• Coronary Heart Disease
• Stable Angina

Interventions

• Yangxin Shengmai
• Yangxin Shengmai placebo
• nitroglycerin tablets

Primary outcomes

• Stopping or reducing rate of the nitroglycerin tablets — Four weeks after treatment
  Number of nitroglycerin tablets used before medication - number of nitroglycerin tablets used after medication) / number of nitroglycerin tablets used before medication × 100%